William P. Mills, III

Phone212 504 6436

Peer Rating
 5.0/5.0
AV® Preeminent

Client Rating

Featured AV Peer Review Rated Lawyer IconFeatured AV Peer Review Rated Lawyer Icon
Printer Friendly VersionEmail this PageDownload to My Outlook ContactsAdd lawyer to My FavoritesCompare this lawyer to other lawyers in your favorites

Experience & Credentials Ratings & Reviews
 

Practice Areas

  • Corporate
  • Corporate Finance
  • Corporate Governance
  • Private Equity
  • Distressed Investing and Mergers & Acquisitions
  • Health Care
  • Mergers & Acquisitions
 
Contact InfoTelephone: 212 504 6436
Fax: 212 504 6666
http://www.cadwalader.com/professionals/william-mills
 
University Georgetown University, A.B., cum laude, 1988
 
Law SchoolFordham University, School of Law, J.D., 1991
 
Admitted1991, Connecticut; 1992, New York; U.S. District Court, Southern District of New York
 
Memberships V2N1 Mar 26, 2014

Videos

• Cadwalader is a Leading Advisor to Corporations and Financial Institutions Sep 18, 2013

 
Biography

William Mills concentrates his practice in the area of corporate law, with emphasis on mergers and acquisitions, securities law, corporate finance and corporate governance. Bill represents clients in a wide range of complex transactions, including mergers, acquisitions, divestitures, public and private securities offerings, proxy contests, spin-offs, restructurings, leveraged buyouts, tender offers, exchange offers, and joint ventures. He also represents investment banks as financial advisers on M&A and other transactions. Bill advises listed public companies in the areas of corporate governance, crisis management, executive compensation, contractual negotiations, and general regulatory compliance.

He received his A.B., cum laude, from Georgetown University and his J.D. from Fordham Law School where he was Notes and Comments Editor of the International Law Journal.

News & Resources

NEWS

News Releases

Cadwalader Advises The Pasha Group on $141 Million Acquisition

Nov 11, 2014

Cadwalader Recognized Among Leading Law Firms in 2015 Edition of IFLR 1000

Oct 21, 2014

Cadwalader Advises Forbes Media LLC on Majority Stake Sale to International Investors

Jul 18, 2014

Cadwalader Recognized Among Leading Firms in The Legal 500 US 2014

Jun 27, 2014

Cadwalader Again Recognized Among Legal Leaders by IFLR 1000

Nov 15, 2013

Cadwalader Recognized in 2013 Edition of The Legal 500 US

Oct 25, 2013

IFLR 1000 Again Names Cadwalader a Leader in Core Transactional Areas of Practice

Nov 06, 2012

The Legal 500 Recognizes More than 15 Cadwalader Practices and 47 of the Firm's Lawyers Across U.S. Offices

Jun 06, 2012

Cadwalader Advises on Transaction Shortlisted for M&A Advisor Magnus Award for Deal of the Year

Nov 16, 2011

IFLR 1000 Again Names Cadwalader a Leader in Core Transactional Areas of Practice

Oct 19, 2011

Cadwalader Named to Winner's Circle at M&A Atlas Awards

Feb 24, 2010

Cadwalader Transaction Named IDD Deal of the Year

Feb 12, 2010

Recent Press

Cadwalader, Simpson Thacher, White & Case on $2.38B KKR-Pfizer Deal

Apr 04, 2011

Cadwalader, Covington Handle Pfizer's King Pharmaceuticals Buy

Oct 12, 2010

New Deals - Lawyers on Major Transactions

Jan 29, 2009

A Long Weekend for Cadwalader, Simpson and Wachtell

Jan 26, 2009

Recognition

Cadwalader Recognized Among Leading Law Firms in 2015 Edition of IFLR 1000

Oct 21, 2014

Cadwalader Recognized Among Leading Firms in The Legal 500 US 2014

Jun 27, 2014

Cadwalader Again Recognized Among Legal Leaders by IFLR 1000

Nov 15, 2013

Cadwalader Recognized in 2013 Edition of The Legal 500 US

Oct 25, 2013

International Financial Law Review's 2013 IFLR 1000

Nov 06, 2012

2012 Legal 500 US

Jun 06, 2012

RESOURCES

Clients & Friends Memos

M&A Update: New York State Court Extends Common Interest Privilege to Merger Talks

Dec 10, 2014

M&A Update: Federal Court Decision in Allergan Control Battle Raises Serious Questions for New Takeover Technique

Nov 06, 2014

M&A Update: No Control, No Conflict, No Problem

Oct 31, 2014

M&A Update: Chancery Court Orders Financial Advisor to Pay Millions in Damages For Aiding and Abetting Breach of Fiduciary Duty

Oct 13, 2014

M&A Update: Delaware Court Upholds Sotheby's Poison Pill Defense Against Activist Citing “Negative Control” as a Corporate Threat

May 05, 2014

M&A Update: Chancery Court Provides Another Lesson for a Reasonable Sale Process

Apr 30, 2014

M&A Update: Ohio Federal Judge Blocks Controlling Stockholder's Tender Offer Based On Target Board's Conflicts and Stockholder Coercion

Apr 17, 2014

M&A Update: Delaware Court's Orchard Enterprises Decision Provides Key Insights For Special Committees In Controlling Stockholder Transactions

Mar 19, 2014

M&A Update: Delaware Supreme Court Upholds Business Judgment Rule Review for Certain Controlling Stockholder Transactions with Dual Minority Protections

Mar 17, 2014

M&A Update: The “Gatekeepers”: Delaware Court Holds Conflicted Financial Advisor Liable for Aiding and Abetting Breach of Fiduciary Duty

Mar 13, 2014

M&A Update: Delaware Court Allows Claims for Breach of Implied Good Faith Covenant in Earn-Out Case

Feb 19, 2014

M&A Update: Highlights from 2013 and Implications for 2014

Jan 17, 2014

Chancery Court Takes Firm Stance on Seller's Pre-Closing Privileged Communication

Nov 22, 2013

Delaware Court Confirms High Bar To Escape Deal

Nov 14, 2013

Recent Amendments to Rule 14a-8 and the Implications for the 2012 Proxy Season

Sep 28, 2011

Events

Financial Advisor Conflicts of Interest

Jun 05, 2014

Tulane Corporate Law Institute

Mar 27, 2014

Newsletter

Quorum

Quorum: March 2014 V2N1

Mar 26, 2014

Videos

Cadwalader is a Leading Advisor to Corporations and Financial Institutions

Sep 18, 2013

Experience
•Forbes Media LLC on its pending sale of a majority stake to a group of international investors as part of the Company's global growth strategy.
•Towers Watson's acquisition of Extend Health
•AngioDynamics' acquisitions of Navilyst Medical, Microsulis Medical, Vortex Medical and Clinical Data
•Elan Corporation's $3.25 billion sale of Tysabri rights to Biogen Idec
•U.S. Treasury's $250 billion TARP Capital Purchase Program
•Pfizer Inc.'s sale of its Capsugel business to KKR
•DPL Inc.'s merger with AES Corp.
•Pfizer Inc.'s acquisition of King Pharmaceuticals
•Bear Stearns Companies Inc. acquisition by JPMorgan Chase
•Pfizer Inc.'s acquisition of Wyeth
•Trian Fund Management in the sale of Wendy's International to Triarc Companies
• Pfizer Inc.'s $16 billion sale of its consumer health care division to Johnson & Johnson
• Xstrata Plc's sale of its Noranda aluminum division to Apollo Management
• Trian Partners' successful proxy contest with H.J. Heinz Company
• StorageTek's merger with Sun Microsystems
• Pfizer Inc.'s acquisitions of Vicuron Pharmaceuticals and Embrex Inc.
• Celanese's sale of its polyvinyl alcohol business to Sekisui Chemical
• RGIS Holdings' sale to the Blackstone Group
• Republic Bancorp Inc.'s merger with Citizens Banking Corporation
• Pfizer Inc.'s acquisition of Warner-Lambert
• U S WEST's merger with Qwest Communications
• MediaOne's merger with AT&T
• Dayton Power & Light's $850 million sale of its private equity portfolio
• Six Flags Inc.'s joint venture to acquire Dick Clark Productions Inc.
• Credit Suisse's acquisitions of Select Portfolio Servicing and Lime Financial
• Del Laboratories' sale to Kelso & Company
• Dianon Systems' sale to Laboratory Corporation of America
• Bear Stearns' acquisition of United Companies Financial Corp.
• Toys R Us, Inc.'s joint venture with Softbank Capital Partners
• Bally Total Fitness' acquisition of Crunch Fitness International
• Dianon Systems' acquisition of UroCor, Inc.
• Moore Medical Corp.'s acquisition by McKesson Corporation
• Six Flags Inc.'s sale of theme parks to Parc 7F- Operations and CNL Income Properties
• ShopRite Supermarkets' acquisition of Big V Supermarkets
• Toysrus.com's joint venture with Amazon.com

As counsel to financial advisors:
•Dell Inc.'s $24 billion going private transaction with Michael Dell and Silver Lake Partners
•Par Pharmaceutical's $1.9 billion sale to TPG
•Cytec's sale of its coating resins business to Advent International
•CVS's $27 billion merger with Caremark
•Cedar Fair's acquisition of Paramount Parks
•The Walt Disney Company's acquisition of Pixar
•Sotheby's Holdings Inc.'s recapitalization transaction with A. Alfred Taubman
•Google Inc.'s investment and strategic alliance with America Online, Inc.
•Harrahs Entertainment's acquisition of Rio Hotel & Casino, Inc.
•Symbion's acquisition by Crestview Partners
•Carreker's acquisition by Checkfree Corporation
•Shire plc's acquisition of New River Pharmaceuticals
•Primedex Health Systems merger with Radiologix, Inc.
•ADVO Inc.'s merger with Valassis Communications
•Caxton-Iseman Capital, Inc.'s acquisition of Valley National Gases Incorporated
•St. Jude Medical, Inc.'s acquisition of Advanced Neuromodulation Systems, Inc.

Securities offerings by:
•Pfizer Inc.
•Elan Corporation
•The Bear Stearns Companies Inc.
•The Dayton Power & Light Company
•Northwest Airline Corporation
•Cosi, Inc.
•Scientific Games Corporation

 
ISLN900968431
 

Documents by this lawyer on Martindale.com

Subscribe to this feed

New York State Court Extends Common Interest Privilege to Merger Talks
Gregory A. Markel,William P. Mills,Brittany Schulman,Martin L. Seidel, December 17, 2014
In a December 4, 2014 decision, the New York Appellate Court, First Department, held that documents and discussions related to negotiation of a merger could be protected by the common interest privilege. The ruling represents a change in New York law which, unlike Delaware, previously limited the...

Federal Court Decision in Allergan Control Battle Raises Serious Questions for New Takeover Technique
Joshua Apfelroth,Gregory A. Markel,William P. Mills,Martin L. Seidel, November 15, 2014
The Federal District Court’s November 4th ruling in Allergan, Inc. vs. Valeant Pharmaceuticals International, Inc. raises “serious questions” for the takeover partnership employed by Valeant and Pershing Square in their hostile bid to acquire Allergan.

No Control, No Conflict, No Problem
Joshua Apfelroth,Gregory A. Markel,William P. Mills,Martin L. Seidel, November 15, 2014
On October 24th, the Delaware Chancery Court dismissed a lawsuit challenging the merger of Crimson Exploration and Contango Oil & Gas. Minority Crimson stockholders alleged that Oaktree Capital Management, Crimson’s largest stockholder with a 33.7% stake, controlled Crimson and caused it...



View Ratings & Reviews
Profile Visibility
#8,587 in weekly profile views out of 96,344 lawyers in New York, New York
#109,668 in weekly profile views out of 1,616,413 total lawyers Overall

Office Information

William P. Mills, III


New YorkNY 10281-0006




Loading...
 

Professional Networking for Legal Professionals Only

Quickly and easily expand your professional
network - join the premier global network for legal professionals only. It's powered by the
Martindale-Hubbell database - over 1,000,000 lawyers strong.
Join Now